Zanthin,Proprietary Hyaluronic Acid, Akba Boswellia Serrata, Biovaflex, Vitamin D3

17 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

590.0%

Death Rate

Active Ingredients

Zanthin,Proprietary Hyaluronic Acid, Akba Boswellia Serrata, Biovaflex, Vitamin D3

Administration Routes

OralUnknown

Species Affected

Dog 17

Most Affected Breeds

Retriever - Labrador 3

Terrier - Rat 2

Crossbred Canine/dog 2

Bulldog 2

Poodle (unspecified) 1

Shepherd Dog - Australian 1

Beagle 1

Pug 1

Collie - Border 1

Terrier - Irish Soft-coated Wheaten 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in 'Neurological') 4

Vomiting 4

Elevated creatinine 3

Not eating 3

Panting 3

Weight loss 2

Pain NOS 2

Diarrhoea 2

Allergy NOS 2

Seizure NOS 1

Elevated alanine aminotransferase (ALT) 1

Elevated serum alkaline phosphatase (SAP) 1

Outcome Breakdown

Recovered/Normal

6 (35.3%)

Ongoing

6 (35.3%)

Outcome Unknown

4 (23.5%)

Died

1 (5.9%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.